PAA 0.00% 22.0¢ pharmaust limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-4

  1. 1,374 Posts.
    lightbulb Created with Sketch. 1057
    Hi Dr Aston
    In the recent " Monsoon Communications Twilight " presentation in which you were involved you mentioned that you followed this sight. You also suggested PAA may promote here as well as elsewhere. The above presentation put together by NZT has factual, positive and eye catching info about PAA and what is on our short term horizon.

    I am sure you have seen the more comprehensive presentations he has done, in many cases much better than some of the mundane stuff that has been released by PAA or by some of PAA's agency's.

    What PAA have been doing in the past with science, whether it be Pitney or Epichem has been out standing. As you mentioned in the Monsoon presentation we have a lot going on in 2022. Now more than ever we need to attract new interest and share holders to PAA.

    It is a time proven fact that if you keep doing the same thing you will get the same results. PAA have consistently shown that statement to be true both in the science and promotion field. The science field has been exceptional. Maybe it is time to change tack in the promotion area. I am sure you would have NZT's contact info, might be worth some consideration.

    Whishing you and all well
    a LTH
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.000(0.00%)
Mkt cap ! $86.90M
Open High Low Value Volume
22.5¢ 22.5¢ 21.0¢ $91.02K 417.3K

Buyers (Bids)

No. Vol. Price($)
1 2325 21.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 119713 2
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
22.0¢
  Change
0.000 ( 5.72 %)
Open High Low Volume
23.0¢ 23.0¢ 21.0¢ 271600
Last updated 15.42pm 06/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.